Lv1
30 积分 2024-12-13 加入
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
2天前
已完结
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
2天前
已完结
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
6天前
已完结
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
2个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
4个月前
已完结
Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous Urticaria
8个月前
已完结
Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal
8个月前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
